Patent Assignment
Reel/Frame 053446/0687
Assignment of Assignor's Interest
Recorded: 2020-08-10
Pages: 9
Assignors
MEHTA, VIMAL D.
Executed: 2020-07-23
RASTELLI, LUCA
Executed: 2020-07-20
MACDOUGALL, JOHN
Executed: 2020-07-22
Assignee
BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, NEW HAVEN, CONNECTICUT, 06511
Covered Properties
(3)
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an OX40 Agonist
PCT:
PCT/US2019/065432 ↗
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an Immune Checkpoint Inhibitor, and an OX40 Agonist
Application:
62/777,350 →
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an OX40 Agonist
Application:
62/790,569 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 10, 2020
From: GUPTA, SNIGDHA
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 053447/0100 →
Assignment of Assignor's Interest
Aug 10, 2020
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053447/0118 →
Assignment of Assignor's Interest
Nov 3, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: ONKOSXCEL THERAPEUTICS, LLC
Reel/Frame 061648/0491 →
Security Interest
Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →
Security Interest
Nov 22, 2024
From: ONKOSXCEL THERAPEUTICS, LLC
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 069377/0185 →